Supplement Table 1. Definitions for Causes of Death

Similar documents
HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Acute Coronary Syndrome

DUKECATHR Dataset Dictionary

a. Ischemic stroke An acute focal infarction of the brain or retina (and does not include anterior ischemic optic neuropathy (AION)).

Diabetic Ketoacidosis

Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University

Supplementary webappendix

Single Seizure of Unknown Cause

Supplementary Table 1. Details of the components of the primary composite endpoint

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM Paramedic, EMT-B and PHRN Optional Continuing Education 2019 #7 Strokes

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017

Statistical analysis plan

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

Supplement materials:

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

SUPPLEMENTAL MATERIAL

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

Chapter 1. Perioperative Evaluation and Management of Surgical Patients. Oral Exam Questions

Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis

Documentation for the IRF Provider

CENTRAL NERVOUS SYSTEM TRAUMA and Subarachnoid Hemorrhage. By: Shifaa AlQa qa

Hanna K. Al-Makhamreh, M.D., FACC Interventional Cardiologist

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

ICD-10 Physician Education. Palliative Care SIP

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

WHI - Volume 8, Section 5 - Outcome Classifications: Cardiovascular Outcomes Page 5-1 SECTION 5 OUTCOME CLASSIFICATIONS: CARDIOVASCULAR OUTCOMES

InterQual Level of Care 2018 Index

4. Which survey program does your facility use to get your program designated by the state?

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Shawke A. Soueidan, MD. Riverside Neurology & Sleep Specialists

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Faculty/Presenter Disclosure

Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)

CMS Limitations Guide - Cardiovascular Services

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

/ / / / / / Hospital Abstraction: Stroke/TIA. Participant ID: Hospital Code: Multi-Ethnic Study of Atherosclerosis

egfr > 50 (n = 13,916)

Physiology #14. Heart Failure & Circulatory Shock. Mohammad Ja far Tuesday 5/4/2016. Turquoise Team. Page 0 of 13

Covered Critical Illness Conditions Appendix

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Online Supplementary Data. Country Number of centers Number of patients randomized

IX: Electrolytes. Sodium disorders. Specific Learning Objectives: Dan Henry, MD Clerkship Director University of Connecticut School of Medicine

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

Acute Stroke Protocols Modified- What s New in 2013

COWLEY COLLEGE & Area Vocational Technical School

Brain Injuries. Presented By Dr. Said Said Elshama

CTA in acute stroke assessment

SUPPLEMENTAL MATERIAL. Supplemental digital content 1, Appendix 1. Ischemic symptoms and electrocardiography

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme

ICU Referral For Common Medical Disorders. Prof. M A Jalil Chowdhury

DIABETES MELLITUS: COMPLICATION. Benyamin Makes Dept. of Anatomic Pathology FMUI - Jakarta

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient

Invokana (canagliflozin) NEW INDICATION REVIEW

Neurosurgical Management of Stroke

Cerebrovascular diseases-2

Thrombolysis administration

AACN PCCN Review. Endocrine

Name: Oasis: Questions EPCP. Professional Development: Diabetes

Lnformation Coverage Guidance

M2 TEACHING UNDERSTANDING PHARMACOLOGY

Cerebrovascular Disorders. Blood, Brain, and Energy. Blood Supply to the Brain 2/14/11

Sepsis Early Recognition and Management. Therese Hughes, PhD, MPA, RN

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

For The Management Of. Diabetic Ketoacidosis

UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh

Catheter-based mitral valve repair MitraClip System

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

Yes No Unknown. Major Infection Information

Documenting in the World of ICD-10 Capturing all your CCs and MCCs Crystal Coen, RN, MSN, FNP-BC NPSS Asheville, NC

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Shock Management. Seyed Tayeb Moradian MSc, Critical Care Nursing Ph.D Candidate. PDF created with pdffactory Pro trial version

Diagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes

2. Subarachnoid Hemorrhage

(For items 1-12, each question specifies mark one or mark all that apply.)

Hypertensives Emergency and Urgency

TOO SWEET TOO STORMY. CONSULTANTS: Dr. Saji James Dr. J. Dhivyalakshmi Dr. P. N. Vinoth. PRESENTOR: Dr. Abhinaya PG I (M.D Paeds)

Supplementary Appendix

Chapter 4: Cardiovascular Disease in Patients With CKD

Cardiovascular Diseases and Diabetes

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62.

Cardiogenic Shock. Carlos Cafri,, MD

EACTS Adult Cardiac Database

Pre-Hospital Stroke Care: Bringing It To The Street. by Bob Atkins, NREMT-Paramedic AEMD EMS Director Bedford Regional Medical Center

WHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE

Cardiac Pathology & Rehabilitation

PAEDIATRIC ACUTE CARE GUIDELINE. Resuscitation Coma

Annual High Claims Survey. Year Ending 31 December 2016

Ticagrelor compared with clopidogrel in patients with acute coronary syndromes the PLATO trial

Transcription:

Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death originating from heart malfunction. Examples include cardiogenic shock, MI and primary cardiac arrest. Cardiac cause of death: Specific definition provided below (check all that apply): Sudden cardiac death (SCD): Death that occurs instantaneously or within 60 minutes after the onset of cardiac symptoms. Classification as sudden cardiac death will be made on the basis of time from onset of cardiac symptoms until death, regardless of subsequent pathologic findings. Patients who are resuscitated from cardiac arrest but die within 60 minutes after arrest will be classified as sudden death. Probable sudden cardiac death: Death that is a consequence of SCD. For example, if the patient is resuscitated from SCD and survives 60 minutes or more, but does not recover function and dies. This would be classified as probable SCD. Also, an unwitnessed death where evidence clearly indicates SCD, could also be classified as probable SCD. Definite myocardial infarction (MI): Death when the patient had an infarction with documentation that patient met the criteria for confirmed Q-wave or non-q-wave MI. Probable MI: Check if there was evidence highly suggestive of necrosis, but no physical documentation (no testing was performed or testing was incomplete). Congestive heart failure: Verification by a physician s statement in the medical record is required. In general, CHF is clinically manifested by one or more features including: dyspnea on exertion (shortness of breath on exertion), bilateral pedal edema, fatigue, orthopnea (sleeping on two or more pillows to facilitate breathing), paroxysmal nocturnal dyspnea (shortness of breath that awakens the patient from sleep). Other findings supporting the clinical manifestations include but are not restricted to: presence of S3 gallop by auscultation, elevated jugular venous pressure >8 cm H 2 0 by physical exam or radiographic evidence of pulmonary congestion. Cardiac procedure: Death within 30 days or within the same hospitalization of a cardiac procedure such as PCI, CABG, or diagnostic angiogram, when death can be reasonably attributed to the procedure (i.e. death would not have been likely to occur had the procedure not been performed). Cardiogenic shock: Defined as a systolic blood pressure < 80 mmhg, which either persists for more than one hour or requires specific treatment for at least one hour. In general, shock is associated with a low urine output, decreased mental acuity or coma, and compensatory

vasoconstriction (decrease in blood vessel caliber). Hypotension without these associated manifestations of low cardiac output will NOT be considered shock. Unwitnessed: Death which occurs more than 60 minutes after last observation of patient. Other: A death for which there is evidence of a primary cardiac cause but has not been or cannot be classified as any of the above. Specify if this is the case. 3.2 Stroke: Stroke is defined as the rapid onset of persistent neurologic deficit attributed to an obstruction or rupture of the brain arterial system. The deficit is not known to be secondary to brain trauma, tumor, infection or other cause. The deficit must last more than 24 hours unless death supervenes or there is demonstrable lesion on CT or MRI compatible with an acute stroke. Type of stroke (check one): Cerebral infarction (CI): The acute onset (minutes to hours) of a focal neurological deficit persisting for longer than 24 hours, with or without CT or MRI documentation, and due to altered circulation to a limited region of the cerebral hemispheres, brainstem or cerebellum. CT or MRI will not show evidence of an intracerebral hemorrhage. Hemorrhagic infarction found on CT or MRI will be classified as infarction. Infarction of the retina, cochlea or labyrinth will be excluded. Intracerebral hemorrhage (ICH): The acute onset of a focal neurological deficit associated with some or all of the following: headache, vomiting, altered level of consciousness, signs of meningeal irritation or blood stained cerebrospinal fluid. CT or MRI or autopsy will demonstrate a parenchymal hemorrhage. The rupture of either an arteriovenous malformation (AVM) or aneurysm resulting in a parenchymal hemorrhage which is noted associated with hemorrhage in the subarachnoid space will be classified as an ICH. Traumatic ICH will be excluded. ICH into an area of brain affected by another disease process such as tumor (primary or secondary) or encephalitis will be excluded. Primary subarachnoid hemorrhage (SAH): The abrupt onset of headache, with or without altered consciousness, with signs of meningeal irritation. A focal neurological deficit may develop acutely or with a delay of hours or days after the other criteria were known to have been present. CT or MRI will show blood in the subarachnoid space. If performed, cerebrospinal fluid examination will show increased red blood cell count or xanthochromia. The imaging studies may show an intraparenchymal hemorrhage which occurred either at or after the onset of the primary subarachnoid hemorrhage. Parenchyma hemorrhage that extends into the subarachnoid space will be classified as an Intracerebral hemorrhage. SAH due to trauma will be excluded. Indeterminant cerebrovascular event (stroke of uncertain type): Clinical evidence of a stroke but insufficient information to establish a pathologic diagnosis.

3.3 Non-cardiovascular atherosclerotic disease other than stroke: Death related to atherosclerotic vascular disease other than stroke but clearly not to cardiac death. Examples include aneurysm and atherosclerotic renal failure. 3.4 Non-cardiovascular medical: Death clearly not related to cardiac disease or atherosclerotic vascular disease, although heart disease may be present. This category includes neoplasm, liver disease and septic shock. 3.5 Non-cardiovascular related to surgery or procedure: Patient died as a direct result of a complication occurring during or within 24 hours after an elective procedure. An example of such elective procedures would be surgery for hernia repair and GI bleeding post procedure. 3.6 Diabetes complication other than cardiovascular disease: Disease complication cause of death (check all that apply): Hypoglycemia: (1.) Sudden death within 30 minutes of a known blood glucose < 40 mg/dl. (2.) Death resulting from MVA, drowning, fall, injury, accident within 30 minutes of a known blood glucose < 50 mg/dl. Diabetic ketoacidosis (DKA): Death from metabolic cause within 24 hours of documented DKA defined by absolute insulin deficiency with hyperglycemia (glucose level >300 mg/dl) with increased lipolysis, increased ketone production (ketone levels positive at 1:4 dilution of serum or greater OR beta hydroxybutyrate > 2 mmol/l), and acidosis (ph<7.30 or HCO3 <15 meq/l). Hyperosmolar hyperglycemic nonketotic coma: Death within 48 or 72 hours of documented blood glucose >600 mg/dl and no other cause (e.g. MI, pancreatitis, sepsis, etc.) Other: If diabetes cause of death is other than one of the above categories, specify cause of death. Specify: Self-explanatory. 3.7 Diabetes-related renal failure: Death with BUN >100, serum creatinine >5.0, serum potassium >6.0, urine protein >300 mg/dl or on dialysis with nephropathy or biopsy proven glomerulosclerosis, or no evidence of renal disease other than diabetic nephropathy. 3.8 Diabetes-related amputation: Non-traumatic amputation required for gangrene, foot ulcer and intractable infection leading to death. 3.9 Accident and trauma: Refers to violent death due to accident, such as automobile accident, drowning, or gunshot wound. 3.10 Suicide: Patient deliberately brings about own death.

3.11 Unknown: If primary cause cannot be determined, record unknown.

5 year KM estimate (n) Supplement Table 2. Five Year Kaplan-Meier Estimates for Non-Procedural MI Events, According to Type of Myocardial Infarction (Q-wave and non-q-wave), and Cardiac Cath or Non-Procedural Myocardial Infarction, According to Initial Treatment Strategy, and According to PCI and CABG Stratum Non-Procedural MI Documented N Q-wave Non-Q All Nonprocedural MI (includes Fatal) Cardiac Death or Nonprocedural MI All Patients 2368 Prompt Coronary Revascularization 1176 2.5% (25) 5.5% (61) 8.8% (96) 13.4% (149) Intensive Medical 1192 2.9% (32) 9.0% (92) 13.3% (138) 15.8% (167) Nominal P-Value 0.41 0.017* 0.009* 0.40 PCI Stratum 1605 Prompt Coronary Revascularization 798 2.3% (17) 6.6% (51) 9.4% (72) 13.3% (105) Intensive Medical 807 2.6% (18) 8.0% (54) 11.4% (79) 13.2% (93) Nominal P-Value 0.93 0.87 0.69 0.29 CABG Stratum 763 Prompt Coronary Revascularization 378 3.0% ( 8) 2.9% (10) 7.6% (24) 13.7% (44) Intensive Medical 385 3.6% (14) 11.2% (38) 17.1% (59) 21.4% (74) Nominal P-Value 0.23 <0.001** 0.0001** 0.006* Insulin Provision 1185 2.1% (22) 8.2% (89) 11.4% (122) 15.0% (164) Insulin Sensitization 1183 3.3% (35) 6.3% (64) 10.7% (112) 14.2% (152) Nominal P-value 0.08 0.03* 0.47 0.45 Cause of Death determined by independent Mortality and Morbidity committee; Includes documented MI s from the Core ECG lab and/or Fatal MI s as determined by death classification *significant at nominal level ** significant after Bonferroni adjustment for multiple tests done in the table

Supplement Table 3. Hazard Ratio of Death or Cardiac Death by Post Randomization Non-procedural MI Status Number of Deaths HR of Death (95% CI) Nominal p-value for equality between HR Number of Cardiac Deaths HR of Cardiac Death* (95% CI) Rev IMT Rev/IMT Rev IMT Rev/IMT All Patients (n = 2368) MI 30 45 0.96 (0.61-1.53) 0.48 19 35 0.78 (0.44 1.36) No MI 107 93 1.17 52 27 1.96* (0.89 1.54) (1.23 3.12) Nominal p-value for equality between HR 0.013* PCI Stratum (n = 1605) MI 19 26 0.66 (0.37 1.20) No MI 72 54 1.37 (0.97 1.96) CABG Stratum (n = 763) MI 11 19 2.1 (1.01 4.52) No MI 35 39 0.88 (0.56 1.39) 0.04* 11 19 0.54 (0.26 1.15) 33 14 2.41* (1.28-4.50) 0.05 8 16 1.50 (0.63 3.54) 19 13 1.47 (0.72 2.97 0.003* 0.97 IP IS IP/IS IP IS IP/IS All Patients (n = 2368) MI 41 34 0.98 (0.62-1.55) No MI 100 100 1.01 (0.76 1.33) 0.93 28 26 0.88 (0.52 1.51) 41 38 1.09 (0.70-1.69) 0.56 censored at last known MI follow-up *significant at nominal level CABG = coronary artery bypass grafting; IP/IS = insulin provision/insulin sensitization; MI = myocardial infarction; PCI = percutaneous coronary intervention; Rev/Med = revascularization/medicine